TrialDrugs in R&D2021

Clinical and Preclinical Single-Dose Pharmacokinetics of VIR-2218, an RNAi Therapeutic Targeting HBV Infection.

Sneha V Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.